KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Gains from Investment Securities (2016 - 2025)

Humana (HUM) has disclosed Gains from Investment Securities for 16 consecutive years, with $122.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Investment Securities changed N/A to $122.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $157.0 million, a N/A change, with the full-year FY2024 number at $50.0 million, changed N/A from a year prior.
  • Gains from Investment Securities was $122.0 million for Q3 2025 at Humana, up from $41.0 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $393.0 million in Q2 2022 to a low of -$167.0 million in Q3 2021.
  • A 4-year average of $95.2 million and a median of $7.5 million in 2021 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: soared 2876.92% in 2021, then plummeted 1900.0% in 2022.
  • Humana's Gains from Investment Securities stood at $8.0 million in 2021, then dropped by 12.5% to $7.0 million in 2022, then decreased by 14.29% to $6.0 million in 2023, then surged by 1933.33% to $122.0 million in 2025.
  • Per Business Quant, the three most recent readings for HUM's Gains from Investment Securities are $122.0 million (Q3 2025), $41.0 million (Q2 2025), and -$12.0 million (Q1 2025).